NDC Pharmacologic Class N0000182636 B Lymphocyte Stimulator-directed Antibody Interactions [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
49401-088Benlysta BelimumabSolutionSubcutaneousGlaxosmithkline LlcHuman Prescription Drug
49401-101Benlysta BelimumabInjection, Powder, Lyophilized, For SolutionIntravenousGlaxosmithkline LlcHuman Prescription Drug
49401-102Benlysta BelimumabInjection, Powder, Lyophilized, For SolutionIntravenousGlaxosmithkline LlcHuman Prescription Drug

There are 3 NDC products with the pharmacologic class B Lymphocyte Stimulator-directed Antibody Interactions [MoA].